3C Bio’s onsite labs have the capacity to fully screen and clear an entire workforce in a single day, or all prospective attendees on the day of an event.
By locating labs onsite, sample collection and testing speed is optimized. Samples go directly into the testing cue, minimizing transport, handling and storage requirements. An event with 2,400 people requires 1 lab onsite; ten labs would be needed for an event or workforce of 24,000.
We need to “Test, Test, Test” and ensure that test results are available in a timely fashion to catch asymptomatic carriers.
3C Bio’s solution is to construct a nationwide network of quickly deployable mobile diagnostic laboratories for rtPCR testing in order to screen at-risk and mission critical communities for SARS-CoV-2 infections—food and transportation workers, health care facilities, schools, critical infrastructure workers—and also provide large scale testing for elective activities like sports, conventions and cultural events.
Optimized for SARS-CoV-2 RT-qPCR testing using FDA EUA approved methods, 3C Bio laboratories are fully self-contained and can operate from 3 to 5 days continuously in remote locations before resupply and service are necessary.
A robotic backbone prepares samples for analysis, reduces human error and can serve as the flexible input for any viral RNA analytical method. This system tests for the presence of virus, which can show up in the body days before antibodies are present. Test results delivered via secure platform, same day.
The machines and methodologies have individually received Emergency Use Authorization by the FDA. Individual laboratories are CLIA/ILAC certified once they are built, and then EUA approved for a specified testing methodology.
3C Bio Announces Formation of Rapid Deployment Mobile Diagnostic Laboratory Company and Winning the XX: Fight the Virus Business Accelerator Competition SAN PEDRO, CA, August 13, 2020 — 3C Bio, Inc. (“3C Bio”), an in vitro diagnostics company that builds, sells, and operates rapidly deployable......